Growth is being fueled by the rising demand for personalized, patient-derived treatments that minimize immune rejection and ...

The financial trajectory of the exosome therapy market is decoupling from the broader, slower-growing regenerative medicine ...

Mesoblast reports early real-world data showing 84% survival in children treated with FDA-approved Ryoncil, as the company expands hospital access and prepares an adult trial.

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial.

Atara Biotherapeutics stock drops on FDA rejection of EBVALLO BLA for serious post-transplant complication. FDA raises new concerns.

CAR-T cell therapy modifies T-cells to target cancer, offering an alternative for patients with non-responsive immune systems. The therapy can potentially clear tumors with one treatment and remain in ...

Q. I am a 45-year-old competitive racquetball player who has had six months of right shoulder pain. The pain is worst on overhead motions while playing. The discomfort also wakes me at night. An MRI ...

The International Society for Stem Cell Research (ISSCR) has released "Charting the Translational Pathway: ISSCR Best Practices for the Development of Pluripotent Stem Cell (PSC)-Derived Therapies," a ...

With around one million people living with Parkinson’s disease in the U.S. — and 90,000 getting new diagnoses each year — the race is on for a cure. Researchers at Memorial Sloan Kettering Cancer ...

The immune system is made up of different types of cells, which have different roles in protecting the body from infection. One type of immune cell called a B cell creates antibodies that attack ...

Stem cell transplants that are a standard treatment for certain blood cancers are out of reach for many patients. The procedure requires cells from a matched donor, but a match isn’t always available.